Geriatric Syndromes Defined and Explained for Oncology Practice

  • Miriam B. Rodin

This chapter addresses three goals. The first is to explain the concept of geriatric syndromes. The second goal is to provide guidance so that geriatric syndromes can be anticipated and recognized in oncology practice. The third is to offer suggestions for managing and preventing selected geriatric complications of cancer treatment. As such, this chapter is not intended to be a pocket guide to geriatrics. It is intended to raise awareness of geriatric syndromes to trigger appropriate geriatric referral as an adjunct to cancer treatment.


Androgen Deprivation Therapy Disease Management Program Comprehensive Geriatric Assessment Decisional Capacity Short Physical Performance Battery 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


  1. 1.
    U.S. Bureau of the Census. Current Population Reports, Special Studies: 65+ in the United States. U.S. Government Printing Office, Washington, DC. 1996;2:8. Publ P23-190.Google Scholar
  2. 2.
    Ries, LAG, Eisner MP, Kosary CL, Hankey BF, Miller BA, Clegg L, et al. (Editors). SEER Cancer Statistics Review, 1973–1999. National Cancer Institute, Bethesda, MD.Google Scholar
  3. 3. Accessed Feb. 19, 2008.
  4. 4.
    Olde-Rikkert MGM, Rigaud A-S, van Hoeyweghen RJ, de Graaf J. Geriatric syndromes: Medical misnomer or progress in geriatrics? Neth J Med 2003;61(3):83–7.PubMedGoogle Scholar
  5. 5.
    Cohen HJ. Biology of aging as related to cancer. Cancer 1994;74 (57):2092–210.PubMedCrossRefGoogle Scholar
  6. 6.
    Lipsitz LA. Dynamics of stability: The physiologic basis of functional health and frailty. J Gerontol Sci Ser A Biol Sci Med Sci 2002;57 (3):15–25.Google Scholar
  7. 7.
    Inouye SK, Studenski S, Tinetti ME, Kuchel GA. Geriatric syndromes: Clinical, research and policy implications of a core geriatric concept. J Am Geriatr Soc 2007;5:780–91.CrossRefGoogle Scholar
  8. 8.
    Carlson RW, Moench S, Hurria A, Balducci L, Blustein HJ, et al. NCCN Task Force Report: Breast cancer in the older woman. J Natl Compreh Cancer Netw 2008,4 (6 Suppl):S1–S25.Google Scholar
  9. 9.
    Extermann M, Aapro M, Bernabei R, Cohen HJ, Droz JP, et al. Use of comprehensive geriatric assessment in older cancer patients: Recommendations from the task force on CGA of the International Society of Geriatric Oncology (SIOG). Crit Rev Oncol Hematol 2005;5 (3):241–52.CrossRefGoogle Scholar
  10. 10.
    Ritchie CS, Locher JL, Roth DL, et al. Unintentional weight loss predicts decline in activities of daily living function and life-space mobility over 4 years among community-dwelling older adults. J Gerontol Med Sci 2008;63A (1):67–75.CrossRefGoogle Scholar
  11. 11.
    Morley JE. Anorexia, body composition and ageing. Curr Opin Clin Nutr Metab Care 2001;4 (1):9–13.PubMedCrossRefGoogle Scholar
  12. 12.
    Morley JE, Thomas DR, Wilson MM. Cachexia: Pathophysiology and clinical relevance. Am J Clin Nutr 2006;83:735–43.PubMedGoogle Scholar
  13. 13.
    Vainio A, Auvininen A. Prevalence of symptoms among patients with advanced cancer: An international collaborative study. Symptom Prevalence Group. J Pain Symp Manage 1996;12 (1):3–10.CrossRefGoogle Scholar
  14. 14.
    Hansell DT, Davies J, Burns HJ. The effects on REE of different tumor types. Cancer 1986;58:1739–44.PubMedCrossRefGoogle Scholar
  15. 15.
    Walsh D, Donnelly S, Rybicki L. The symptoms of advanced cancer: Relationship to age, gender and performance status in 1000 patients. Supp Care Cancer 2000;8 (3):175–9.CrossRefGoogle Scholar
  16. 16.
    Dewys WD, Begg C, Lavin PT, et al. Prognostic effect of weight loss prior to chemotherapy in cancer patients. Eastern Cooperative Oncology Group. Am J Med 1980;69 (4):491–7.PubMedCrossRefGoogle Scholar
  17. 17.
    Reuben DB, Mor V, Hiris J. Clinical symptoms and length of survival in patients with terminal cancer. Arch Intern Med 1988;148 (7):1586–91.PubMedCrossRefGoogle Scholar
  18. 18.
    Balducci L. Aging, frailty and chemotherapy. Cancer Control 2007;14 (1):7–12.PubMedGoogle Scholar
  19. 19.
    Fried LP, Ferrucci L, Darer J, Williamson JD, Anderson G. Untangling the concepts of disability, frailty, and comorbidity: Implications for improved targeting and care. J Gerontol A Biol Sci Med Sci 2004;59 (3):255–63.PubMedCrossRefGoogle Scholar
  20. 20.
    Doherty TJ. Invited review: Aging and sarcopenia. J Appl Physiol 2003;95 (4):1717–27.PubMedGoogle Scholar
  21. 21.
    Bruera E, Carraro S, Roca E, et al. Association between malnutrition and caloric intake, emesis, psychological depression, glucose taste and tumor mass. Cancer Treat Rep 1984;68 (6):873–6.PubMedGoogle Scholar
  22. 22.
    Strasser F, Bruera ED. Update on anorexia and cachexia. Hematol Oncol Clin N Am 2002;16:589–617.CrossRefGoogle Scholar
  23. 23.
    Dunlop R. Clinical epidemiology of cancer cachexia. In: E. Bruera, I. Higginson (Editors), Cachexia-Anorexia in Cancer Patients. Oxford University Press, Oxford. 1996; pp. 76–82.Google Scholar
  24. 24.
    The Elderly Lung Cancer Vinorelbine Italian Study Group. Effects of vinorelbine on quality of life and survival of elderly patients with non-small-cell lung cancer. J Natl Cancer Inst 1999;91 (1):66–72.CrossRefGoogle Scholar
  25. 25.
    Cunningham D, Pyrhonen S, James RD, et al. Randomised trial of irinotecan plus supportive care versus supportive care alone after flurouracil failure for patients with metastatic colorectal cancer. Lancet 1998;352 (9138):141308.CrossRefGoogle Scholar
  26. 26.
    Wilson M, Thomas DR, Rubenstein LZ, Chibnall JT, Anderson S, et al. Appetite assessment: Simple appetite assessment questionnaire predicts weight loss in community-dwelling adults and nursing home residents. Am J Clin Nutr 2005;82 (5):1074–81.PubMedGoogle Scholar
  27. 27.
    Neelemat F, Kruizinga HM, de Vet HC, Seidel JC, Butterman M, van Bokhorst-de van der Scheueren MA. Screening for malnutrition in hospital outpatients. Can the SNAQ malnutrition screening tool also be applied to this population? Clin Nutr 2008,27 (3):439–46.CrossRefGoogle Scholar
  28. 28.
  29. 29.
    Tinnetti ME, Williams TF, Mayewski R. Fall risk index for elderly patients based on number of chronic disabilities. Am J Med 1986;80:429–34.CrossRefGoogle Scholar
  30. 30.
    Shahinian VB, Kuo YF, Freeman JL, Goodwin JS. Risk of fracture after androgen deprivation for prostate cancer. N Engl J Med 2005;352 (2):154–64.PubMedCrossRefGoogle Scholar
  31. 31.
    Smith MR, Lee WC, Brandman J, et al. Risk of fracture after androgen deprivation for prostate cancer. J Clin Oncol 2005;352:154–64.Google Scholar
  32. 32.
    Greenspan SL, Brutsky A Lembersky BC, Bhattacharya R, Vujevich KT, et al. Risedronate prevents bone loss in breast cancer survivors. J Clin Oncol 2008;26 (16):44–52.CrossRefGoogle Scholar
  33. 33.
    Greenspan SL, Nelson JB, Trump DL, Wagner JM, Miller ME, Perera S, Resnick NM. Skeletal health after continuation, withdrawal, or delay of alendronate in men with prostate cancer undergoing androgen deprivation therapy. J Clin Oncol 2008;26 (27):426–34.CrossRefGoogle Scholar
  34. 34.
    Tinetti ME. Performance-oriented assessment of mobility problems in elderly patients. J Am Geriatr Soc 1986;34(2):119–26. Download tool at: Scholar
  35. 35.
    Guralnik JM, Ferrucci L, Simonsick EM, Salive ME, Wallace RB. Lower-extremity function in persons over the age of 70 years as a predictor of subsequent disability. N Engl J Med 1995;332(9):556–61. Download tool at: Scholar
  36. 36.
    Fortinsky RH, Iannuzzi-Sucich M, Baker DI, et al. Fall-risk assessment and management in clinical practice: Views from healthcare providers. J Am Geriatr Soc 2004;52 (9):1522–6.PubMedCrossRefGoogle Scholar
  37. 37.
    Bylow K, Dale W, Mustian K, Stadler WM, Rodin M, Hall W, Lachs M, Mohile SG. Falls and physical performance deficits in older prostate cancer patients undergoing androgen deprivation therapy. Urology 2008;72 (2):422–7.PubMedCrossRefGoogle Scholar
  38. 38.
    Hurria A, Gupta S, Zauderer M, Zuckerman EL, Cohen HJ, et al. Developing a cancer-specific geriatric assessment: A feasibility study. Cancer 2005;104 (9):1998–2005.Google Scholar
  39. 39.
    Walz J, Gallina A, Perrotte P, et al. Clinicians are poor raters of life-expectancy before radical prostatectomy or definitive radiotherapy for localized prostate cancer. Br J Urol Int 2007;100:1254–8.CrossRefGoogle Scholar
  40. 40.
    Markson LJ, Kern DC, Annas GJ, et al. Physician assessment of patient competence. J Am Geriatr Soc 1994;42:1074–80.PubMedGoogle Scholar
  41. 41.
    Marson DC, Earnst KS, Jamil F, et al. Consistency of physicians' legal standard and personal judgments of competency in patients with Alzheimer's disease. J Am Geriatr Soc 2000;48:911–8.PubMedGoogle Scholar
  42. 42.
    Gupta SK, Lamont EB. Patterns of presentation, diagnosis, and treatment in older patients with colon cancer and comorbid dementia. J Am Geriatr Soc 2004;52:1681–7.PubMedCrossRefGoogle Scholar
  43. 43.
    Rodin MB, Mohile SG. Assessing decisional capacity in the elderly cancer patient. Sem Oncol 2008;35(6):625–32.CrossRefGoogle Scholar
  44. 44.
    Karlawish J. Measuring decision-making capacity in cognitively impaired individuals. Neurosignals 2008;16:91–8.PubMedCrossRefGoogle Scholar
  45. 45.
    Casarett DJ, Karlawish JH, Hirschman KB. Identifying ambulatory cancer patients at risk of impaired capacity to consent to research. J Pain Symp Manage 2003;26:615–24.CrossRefGoogle Scholar
  46. 46.
    Bial AK, Schilsky RL, Sachs GA. Evaluation of cognition in cancer patients: Special focus on the elderly. Crit Rev Oncol Hematol 2006;60:242–55.PubMedCrossRefGoogle Scholar
  47. 47.
    Moye J, Karel MJ, Gurrera RJ. Neuropsychological predictors of decision-making capacity over 9 months in mild-to-moderate dementia. J Gen Intern Med 2006:21:78–83.PubMedCrossRefGoogle Scholar
  48. 48.
    Young J, Inouye SK. Delirium in older people. Br Med J 2007;334:842–6.CrossRefGoogle Scholar
  49. 49.
    Fitten LJ, Waite MS. Impact of medical hospitalization on treatment decision-making: Capacity in the elderly. Arch Intern Med 1990;150:1717–21.PubMedCrossRefGoogle Scholar
  50. 50.
    Inouye SK, Charpentier PA. Precipitating factors for delirium in hospitalized elderly persons: Predictive model and interrelationship with baseline vulnerability. J Am Med Assoc 1990;275:852–7.Google Scholar
  51. 51.
    Inouye SK, Bogardus ST, Jr., Baker DI, et al. The Hospital Elder Life Program: A model of care to prevent cognitive and functional decline in older hospitalized patients. J Am Geriatr Soc 2000;48:1697–706.PubMedGoogle Scholar
  52. 52.
    Flaherty JH, Tariq SH, Raghavan S, Bakshi S, Moinuddin A, Morley JE. A model for managing delirious older patients. J Am Geriatr Soc 2003;51(7):1031–5.PubMedCrossRefGoogle Scholar
  53. 53.
    Inouye SK, van Dyck CH, Alessi CA, et al. Clarifying confusion: The Confusion Assessment Method: A new method for detection of delirium. Ann Intern Med 1990;113 (12):941–8.PubMedGoogle Scholar
  54. 54.
    Breitbart W, Rosenfeld B, Roth A, et al. The Memorial Delirium Assessment Scale. J Pain Symp Manage 1997;13 (3):128–37.CrossRefGoogle Scholar
  55. 55.
    Trzepacz PT, Mittal D, Torres R, et al. Validations of the Delirium Rating Scale Revised-98 compared with the Delirium Rating Scale and the Cognitive Test for Delirium. J Neuropsychiatry Clin Neurosci 2001;13 (2):229–42.PubMedCrossRefGoogle Scholar
  56. 56.
    Bosisio M, Caraceni A, Grassi L. Italian Delirium Study Group. Phenomenology of delirium in cancer patients as described by the Memorial Sloan Kettering Assessment Scale (MDAS) and the Delirium Rating Scale (DRS). Psychosomatics 2006;47 (6):471–8.PubMedCrossRefGoogle Scholar
  57. 57.
    Mitnitski A, Bao L, Rockwood K. Going from bad to worse: A stochastic model of transitions in deficit accumulation in relation to mortality. Mech Ageing Dev 2006;127:490–3.PubMedCrossRefGoogle Scholar
  58. 58.
    Gurwitz JH. Polypharmacy: A new paradigm for quality drug therapy in the elderly? Arch Intern Med 2004;164:1957–9.PubMedCrossRefGoogle Scholar
  59. 59.
    Kaufman DW, Kelly JP, Rosenberg AL, et al. Recent patterns of medication use in the ambulatory adult population of the United States: The Slone survey. J Am Med Assoc 2002;287:337–44.CrossRefGoogle Scholar
  60. 60.
    Goulding MR. Inappropriate medication prescribing for elderly ambulatory care patients. Arch Intern Med 2004;164:305–12.PubMedCrossRefGoogle Scholar
  61. 61.
    Lee PY, Alexander KP, Hammill BG, Pasquali SK, Peterson ED. Representation of elderly persons and women in published randomized trials of acute coronary syndromes. J Am Med Assoc 2001;286:708–13.CrossRefGoogle Scholar
  62. 62.
    Masoudi FA, Havranek EP, Wolfe P, et al. Most hospitalized older persons do not meet the enrollment criteria for clinical trials in heart failure. Am Heart J 2003;146:250–7.PubMedCrossRefGoogle Scholar
  63. 63.
    Krumholz H, Gross CP, Peterson ED, et al. Is there evidence of implicit exclusion criteria for elderly subjects in randomized trials? Evidence from the GUSTO-1 study. Am Heart J 2003;146:839–47.PubMedCrossRefGoogle Scholar
  64. 64.
    Rich MW, Beckham V, Wittenberg C, Leven CL, Freedland KE, Carney RM. A multidisciplinary intervention to prevent the readmission of elderly patients with congestive heart failure. N Engl J Med 1995;333:1190–5.PubMedCrossRefGoogle Scholar
  65. 65.
    Huang ES, Zhang Q, Gandra N, Chin MH, Meltzer DO. The effect of comorbid illness and functional status on the expected benefits of intensive glucose control in older patients with type 2 diabetes: A decision analysis. Ann Intern Med 2008;149 (1):11–9.PubMedGoogle Scholar
  66. 66.
    Beckett NS, Peters R, Fletcher AE, Staessen JA, Liu L, et al. Hyvet Study Group. Treatment of hypertension in patients 80 years of age or older. N Engl J Med 2008;358 (1):1887–98.PubMedCrossRefGoogle Scholar
  67. 67.
    Riechelman RP, Sad ED. A systematic review on drug interactions in oncology. Cancer Invest 2006;24:704–12.CrossRefGoogle Scholar
  68. 68.
    Budnitz DS, Shehab N, Kegler SR, Richard CL. Medication use leading to emergency department visits for adverse drug events in older adults. Ann Intern Med 2007;147:755–65.PubMedGoogle Scholar
  69. 69.
    Sokol KC, Knudsen JF, Li MM. Polypharmacy in older oncology patients and the need for an interdisciplinary approach to side-effect management. J Clin Pharm Ther 2007;32:169–75.PubMedCrossRefGoogle Scholar
  70. 70.
    Yeung KS, Gubili J. Clinical guide to herb-drug interactions in oncology. J Soc Integrative Oncol 2007;5 (3):113–7.CrossRefGoogle Scholar
  71. 71. Accessed Nov. 11, 2008.
  72. 72. Accessed Nov. 11, 2008.
  73. 73. Accessed November 11, 2008.
  74. 74.
    Fick DM, Cooper JW, Wade WE, et al. Updating the Beers criteria for potentially inappropriate medication use in older adults: Results of a U.S. consensus panel of experts. Arch Intern Med 2003;163 (2):2716–24.PubMedCrossRefGoogle Scholar
  75. 75.
    Milton JC, Hill-Smith I, Jackson SHD. Prescribing for older people. Br Med J 2008;36:606–9.CrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2009

Authors and Affiliations

  1. 1.Department of MedicineSt. Louis University Medical SchoolSaint LouisUSA

Personalised recommendations